Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
The Bedford Lab has worked extensively in the field of viral evolutionary forecasting. In this context, we’ve developed models to estimate fitness of seasonal influenza variants from genetic sequence data and to then use fitness estimates to forecast variant frequencies (Huddleston et al., eLife, 2020). We’ve taken a similar approach to forecasting SARS-CoV-2 variants in applying multinomial logistic regression (MLR) to estimate variant fitness and to project frequencies forward in time (Abousamra et al., PLoS Comput Biol, 2024). This approach underlies our live SARS-CoV-2 evolutionary forecasts at nextstrain.org/sars-cov-2/forecasts. Our influenza forecasts are directly utilized by the World Health Organization in the twice yearly vaccine strain selection meetings for seasonal influenza.
Recent advances in deep learning, especially transformer-based language models for protein sequences (see ESM3) and DNA sequences (see Evo2), present exciting new avenues to enhance evolutionary predictions. These models, trained to predict residues or nucleotides based on sequence context, have potential to significantly improve predictions of variant fitness and evolution.
We have an opening for a Post-Doctoral Research Fellow in the Bedford Lab at the Fred Hutch Cancer Center to work on developing and applying DNA and protein language models to understand and forecast viral evolution.
MINIMUM QUALIFICATIONS:
The candidate must be responsible, organized, and able to independently pursue research projects.
To apply please also submit
The annual base salary range for this position is from $77,976 to $95,014, and pay offered will be based on experience and qualifications.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (22 days per year), paid sick leave (up to 30 calendar days per occurrence of a qualifying reason), paid holidays (up to 13 days per year), and paid parental leave (up to 4 weeks).
Software Powered by iCIMS
www.icims.com